...
首页> 外文期刊>Oncology reports >Inhibitory effects of the ethanol extract of Gleditsia sinensis thorns on human colon cancer HCT116 cells in vitro and in vivo.
【24h】

Inhibitory effects of the ethanol extract of Gleditsia sinensis thorns on human colon cancer HCT116 cells in vitro and in vivo.

机译:皂角乙醇提取物在体外和体内对人结肠癌HCT116细胞的抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The thorns of Gleditsia sinensis have traditionally been used in the treatment of several diseases, which includes their use as anti-tumor agents, but there has been no scientific evidence of this anti-tumor effect. However, the present study has identified a novel mechanism for the anti-tumor effect of Gleditsia sinensis thorns in the treatment of colon cancer. Treatment with the ethanol extract of Gleditsia sinensis thorns (EEGS) resulted in significant growth inhibition together with G2/M-phase cell cycle arrest at a dose of 600 microg/ml (IC50) in HCT116 cells. In addition, treatment with EEGS induced p27 expression and down-regulated expression of cyclins and cyclin-dependent kinases. Moreover, EEGS treatment induced phosphorylation of extracellular signal-regulated kinases (ERK), p38 MAP kinase and JNK (c-Jun N-terminal kinases). Among the pathways examined, only PD98059 (ERK-specific inhibitor) abolished EEGS-dependent p27 expression. Similarly, suppression of ERK function reversed EEGS-mediated cell proliferation inhibition and decreased cell cycle proteins. In addition, tumor necrosis factor-alpha (TNF-alpha)-induced matrix metalloproteinase-9 (MMP-9) expression was inhibited by EEGS treatment via decreased transcriptional activity of both activator protein-1 (AP-1) and nuclear factor-kappaB. Finally, EEGS treatment significantly reduced tumor sizes in HCT116 cell-xenografted tumor tissues, which was associated with the changed levels of ERK phosphorylation, p27 and MMP-9 expression. Overall, these results have identified a novel molecular mechanism for EEGS in the treatment of colon cancer and might provide a theoretical basis for the potential therapeutic use of EEGS in the treatment of malignancies.
机译:传统上已将中华皂角的刺用于治疗多种疾病,包括将其用作抗肿瘤剂,但尚无科学证据证明这种抗肿瘤作用。然而,本研究发现了一种新的抗皂角刺在结肠癌治疗中的抗肿瘤作用的机制。用中华皂角刺(EEGS)乙醇提取物处理可显着抑制HCT116细胞的生长,并以600μg/ ml(IC50)的G2 / M期细胞周期阻滞。此外,用EEGS处理可诱导p27表达以及细胞周期蛋白和细胞周期蛋白依赖性激酶的表达下调。此外,EEGS治疗诱导了细胞外信号调节激酶(ERK),p38 MAP激酶和JNK(c-Jun N-末端激酶)的磷酸化。在检查的途径中,只有PD98059(ERK特异性抑制剂)废除了EEGS依赖性p27表达。同样,抑制ERK功能可逆转EEGS介导的细胞增殖抑制作用,并减少细胞周期蛋白。此外,通过激活蛋白-1(AP-1)和核因子-kappaB的转录活性降低,EEGS处理可抑制肿瘤坏死因子-α(TNF-α)诱导的基质金属蛋白酶-9(MMP-9)的表达。 。最后,EEGS治疗显着减少了HCT116细胞异种移植肿瘤组织中的肿瘤大小,这与ERK磷酸化,p27和MMP-9表达水平的改变有关。总体而言,这些结果确定了EEGS在结肠癌治疗中的新型分子机制,并可能为EEGS在恶性肿瘤治疗中的潜在治疗用途提供理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号